| Recruitment status | Terminated |
| Unique ID issued by UMIN | UMIN000020731 |
| Receipt No. | R000023918 |
| Official scientific title of the study | Randomized controlled trial of prior minimal endoscopic spincteroplasty /EST + endoscopic ballon sphincteroplasty /EBS and EST in a choledocholith treatment |
| Date of disclosure of the study information | 2016/03/01 |
| Last modified on | 2018/01/29 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Randomized controlled trial of prior minimal endoscopic spincteroplasty /EST
+ endoscopic ballon sphincteroplasty /EBS and EST in a choledocholith treatment |
|
| Title of the study (Brief title) | Randomized controlled trial of prior minimal EST + EBS and EST in a choledocholith treatment | |
| Region |
|
|
| Condition | ||
| Condition | choledocholith | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | We investigated the efficacy of prior minimal EST+ EBS in a choledocholith treatment |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Incidence of complication
after the procedure in 7days |
| Key secondary outcomes | The stone clearance rate, and the number of ERCPs required for complete stone clearance. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | minimal EST+EBS group | |
| Interventions/Control_2 | EST group | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1,the presence of choledocholith < 8mm in
CT,MRI,US,EUS within a month 2ECOS PS is 0 or 1 3Criteria blood test Neutrophils < 1500/ml,Plt<80000,Hb>9.0, Cre<1.5mg/dl,AST/ALT<92/107,T-Bil<2mg/dL, Alb2.8g/dL,PT-INR<1.5 4,the patient who is expected to live more than three month |
|||
| Key exclusion criteria | 1,a history of EST or EBS
2,a history of Billroth 2 or Roux-en-Yanatomy 3,pancreatobiliary malignancy 4,choledochoduodenalfistula , concurrent hepatolithiasis 5,the patient who has a heart disease .a history of congested heart failure, cardiac infarction .a history of serious arrhythmia, hypertention .a history of coronary disease 6,the patient who has a mental disease |
|||
| Target sample size | 300 | |||
| Research contact person | |
| Name of lead principal investigator | Jin Kan Sai |
| Organization | Juntendo University Hospital |
| Division name | Department of Gastroenterology |
| Address | 3-1-3 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan |
| TEL | 03-3813-3111(70227) |
| ivo@juntendo.ac.jp | |
| Public contact | |
| Name of contact person | Ryo Kanazawa |
| Organization | Juntendo University Hospital |
| Division name | Department of Gastroenterology |
| Address | 3-1-3 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan |
| TEL | 03-3813-3111(70226) |
| Homepage URL | |
| rkanaza@juntendo.ac.jp | |
| Sponsor | |
| Institute | Juntendo University Hospital
Department of Gastroenterology |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Juntendo University Hospital
Department of Gastroenterology |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Terminated | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023918 |